ACE2 and Hyperglycemia: These outcomes are mediated by hyperglycemia and blood glucose fluctuations, expressions of furin proteins and ACE2 receptor, ACE2 autoantibodies production, imbalances in immune and inflammatory pathways, diabetes-related complications as well as lung injury in diabetes.